MHR Fund Management LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), MHR Fund Management LLC reported 9 stock positions worth $917.0 million. Its top holding was Telesat (TSAT) at 25.9% of the portfolio, followed by Iovance Biotherapeutics (IOVA, 24.6%) and Lions Gate Entmnt (17.2%). Compared with Q2 2024, it opened 1 new position and sold out of 1. The biggest buy was a new position in Hafnia (HAFN) and the biggest sale an exit from Scholastic (SCHL).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001277742
- Portfolio Value
- $917.0M (Q3 2024)
- SEC Filing
- 0001011438-24-000670 ↗ filed Nov 14, 2024
Holdings Value
Holdings 9 stocks · $917.0M
| TSAT Telesat Corp. | 25.90% | 18,035,092 | $237.5M | No change |
| IOVA Iovance Biotherapeutics Inc. | 24.57% | 23,997,103 | $225.3M | No change |
| LIONS GATE ENTMNT CORP | 17.19% | 20,127,661 | $157.6M | No change |
| LGF.B Lions Gate Entertainment-B | 11.40% | 15,105,523 | $104.5M | No change |
| APO Apollo Global Management Inc. | 9.25% | 679,000 | $84.8M | No change |
| TWI Titan International Inc. | 7.10% | 8,005,000 | $65.1M | No change |
| HAFN Hafnia Ltd. | 4.49% | 5,751,337 | $41.2M | New |
| DVAX Dynavax Technologies Corp. | 0.05% | 44,499 | $496K | No change |
| OPTU Optimum Communications Inc. Class A filed as ALTICE USA INC | 0.04% | 167,800 | $413K | No change |
Portfolio Sells Q2 2024 → Q3 2024
| SCHL Scholastic Corp. | Sold out | 0.00% | −0.56 |
Portfolio Buys Q2 2024 → Q3 2024
| HAFN Hafnia Ltd. | New | 4.49% | +4.49 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 11 | $1.9B | TSAT, LION, HAFN, IOVA, STRZ |
| Q1 2026 | 10 | $1.4B | TSAT, LION, HAFN, IOVA, APO |
| Q4 2025 | 10 | $1.2B | TSAT, LION, HAFN, IOVA, APO |
| Q3 2025 | 10 | $1.0B | TSAT, LION, HAFN, IOVA, APO |
| Q2 2025 | 9 | $901.6M | TSAT, LION, HAFN, APO, IOVA |
| Q1 2025 | 9 | $832.0M | TSAT, LIONS GATE ENTMNT CORP, LGF.B, IOVA, APO |
| Q4 2024 | 9 | $904.4M | TSAT, IOVA, LIONS GATE ENTMNT CORP, LGF.B, APO |
| Q3 2024 | 9 | $917.0M | TSAT, IOVA, LIONS GATE ENTMNT CORP, LGF.B, APO |
| Q2 2024 | 9 | $820.6M | IOVA, LIONS GATE ENTMNT CORP, TSAT, LGF.B, APO |
| Q1 2024 | 10 | $1.0B | IOVA, LIONS GATE ENTMNT CORP, TSAT, LGF.B, TWI |